View drug registration information details.
Items | Registration information |
ID | 2173 |
No | 2173 |
Brand Name | BRULEXIN 125 MG |
Ingredients | CEFALEXIN MONOHYDRATE BP EQ. TO ANHYDROUS CEFALEXIN 125 MG/5 ML |
Dosage Form | POWDER FOR SUSPENSION |
Primary Packaging | BOTTLE |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | 60 ML/BOTTLE/CARTON |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | RESPIRATORY TRACT INFECTION, SKIN AND SOFT TISSUE INFECTIONS, BONE AND JOINT INFECTIONS, GENITOURINARY INFECTIONS, INCLUDING ACUTE PROSTATITIS AND DENTAL INFECTIONS. |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OFF WHITE TO LIGHT ORANGE FREE FLOWING GRANULAR POWDER FORMING ORANGE COLORED SUSPENSION ON RECONSTITUTION |
Note | |
License Owner | POUNSAB PHARMA CO.,LTD |
Manufacturer | BRAWN LABORATORIES LIMITED |
Country | INDIA |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 01 I 4643/19 |
FDD Registration Date | 06-DEC-2022 |
Expiry Date | 05-DEC-2025 |
Back to drug list
|